• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为抗癌剂的DMDP衍生物的比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)三维定量构效关系分析

CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents.

作者信息

Srivastava Vivek, Kumar Ashutosh, Mishra Bhartendu Nath, Siddiqi Mohammad Imran

机构信息

Department of biotechnology, Institute of engineering and technology, Sitapur road, Lucknow 21.

出版信息

Bioinformation. 2008 Jun 27;2(9):384-91. doi: 10.6026/97320630002384.

DOI:10.6026/97320630002384
PMID:18795111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2533057/
Abstract

Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) based on three dimensional quantitative structure-activity relationship (3D-QSAR) studies were conducted on a series (78 compounds) of 2, 4-diamino-5-methyl-5-deazapteridine (DMDP) derivatives as potent anticancer agents. The best prediction were obtained with a CoMFA standard model (q(2) = 0.530, r(2) = 0.903) and with CoMSIA combined steric, electrostatic, hydrophobic and hydrogen bond donor fields (q(2) = 0.548, r(2) = 0.909). Both models were validated by a test set of ten compounds producing very good predictive r(2) values of 0.935 and 0.842, respectively. CoMFA and CoMSIA contour maps were then used to analyze the structural features of ligands to account for the activity in terms of positively contributing physiochemical properties such as steric, electrostatic, hydrophobic and hydrogen bond donor fields. The resulting contour maps produced by the best CoMFA and CoMSIA models were used to identify the structural features relevant to the biological activity in this series of analogs. This study suggests that the highly electropositive substituents with low steric tolerance are required at 5 position of the pteridine ring and bulky electronegatve substituents are required at the meta-position of the phenyl ring. The information obtained from CoMFA and CoMSIA 3-D contour maps can be used for the design of deazapteridine-based analogs as anticancer agents.

摘要

基于三维定量构效关系(3D-QSAR)研究,对一系列(78种化合物)作为强效抗癌剂的2,4-二氨基-5-甲基-5-脱氮蝶啶(DMDP)衍生物进行了比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)。使用CoMFA标准模型(q(2)=0.530,r(2)=0.903)以及结合了空间、静电、疏水和氢键供体场的CoMSIA模型(q(2)=0.548,r(2)=0.909)获得了最佳预测结果。两个模型均通过一组十种化合物的测试集进行验证,分别产生了非常好的预测r(2)值0.935和0.842。然后使用CoMFA和CoMSIA等高线图分析配体的结构特征,以根据诸如空间、静电、疏水和氢键供体场等具有正向贡献的物理化学性质来解释活性。由最佳CoMFA和CoMSIA模型生成的等高线图用于识别该系列类似物中与生物活性相关的结构特征。该研究表明,在蝶啶环的5位需要具有低空间耐受性的高正电取代基,而在苯环的间位需要大体积的负电取代基。从CoMFA和CoMSIA三维等高线图获得的信息可用于设计基于脱氮蝶啶的类似物作为抗癌剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7da9/2533057/091dffe182d5/97320630002384F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7da9/2533057/180174a0c5d0/97320630002384F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7da9/2533057/091dffe182d5/97320630002384F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7da9/2533057/180174a0c5d0/97320630002384F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7da9/2533057/091dffe182d5/97320630002384F2.jpg

相似文献

1
CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents.作为抗癌剂的DMDP衍生物的比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)三维定量构效关系分析
Bioinformation. 2008 Jun 27;2(9):384-91. doi: 10.6026/97320630002384.
2
CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.二芳氧基-亚甲基菲衍生物作为抗结核药物的比较分子力场分析和比较分子相似性指数分析
J Mol Model. 2007 Jan;13(1):99-109. doi: 10.1007/s00894-006-0124-0. Epub 2006 Jun 21.
3
Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors.基于对接的1,3,4-恶二唑-2-酮衍生物作为脂肪酸酰胺水解酶(FAAH)抑制剂的3D-QSAR研究
Int J Mol Sci. 2021 Jun 6;22(11):6108. doi: 10.3390/ijms22116108.
4
3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models.CCR2B受体拮抗剂的3D-QSAR研究:基于CoMFA/CoMSIA模型深入了解(R)-3-氨基吡咯烷系列分子的结构要求。
J Pharm Bioallied Sci. 2012 Apr;4(2):123-33. doi: 10.4103/0975-7406.94813.
5
3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.作为丙型肝炎病毒NS5B聚合酶抑制剂的苯并咪唑衍生物的3D QSAR和分子对接研究
J Chem Inf Model. 2008 Jan;48(1):42-55. doi: 10.1021/ci700266z. Epub 2007 Dec 13.
6
3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.使用比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)对T型钙通道阻滞剂进行的三维定量构效关系(3D QSAR)研究。
Bioorg Med Chem. 2004 Apr 1;12(7):1613-21. doi: 10.1016/j.bmc.2004.01.028.
7
CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.作为 GPR40 调节剂的 3-芳基-3-乙氧基丙酸衍生物的 CoMFA、CoMSIA 和 HQSAR 分析。
Curr Drug Discov Technol. 2020;17(1):100-118. doi: 10.2174/1570163815666180829144431.
8
3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.基于从 HIV-1 蛋白酶抑制剂复合物中得出的 HOE/BAY-793 类似物的理论活性构象的 3D-QSAR CoMFA/CoMSIA 模型。
Eur J Med Chem. 2009 Nov;44(11):4344-52. doi: 10.1016/j.ejmech.2009.05.016. Epub 2009 May 23.
9
CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.作为5-HT6拮抗剂的N1-芳基磺酰基吲哚化合物的比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)三维定量构效关系研究
Bioorg Med Chem. 2004 Aug 1;12(15):3977-85. doi: 10.1016/j.bmc.2004.06.007.
10
3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents.3D-QSAR 研究三氮唑哌嗪酰胺二肽基肽酶-4 抑制剂作为抗糖尿病药物。
SAR QSAR Environ Res. 2009 Jul;20(5-6):519-35. doi: 10.1080/10629360903278677.

引用本文的文献

1
A QSAR model of Olanzapine derivatives as potential inhibitors for 5-HT2A Receptor.奥氮平衍生物作为5-HT2A受体潜在抑制剂的定量构效关系模型。
Bioinformation. 2017 Oct 31;13(10):339-342. doi: 10.6026/97320630013339. eCollection 2017.
2
3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.作为多药耐药蛋白-1(MRP1)抑制剂的塔里夸德类似物的3D-QSAR及等高线图分析
Int J Pharm Sci Res. 2016 Feb;7(2):554-572. doi: 10.13040/IJPSR.0975-8232.7(2).554-72. Epub 2016 Feb 1.
3
Design and prediction of new anticoagulants as a selective Factor IXa inhibitor via three-dimensional quantitative structure-property relationships of amidinobenzothiophene derivatives.

本文引用的文献

1
Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.比较分子场分析(CoMFA)。1. 形状对类固醇与载体蛋白结合的影响。
J Am Chem Soc. 1988 Aug 1;110(18):5959-67. doi: 10.1021/ja00226a005.
2
Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase.2,4-二氨基-5-脱氮蝶啶衍生物的抗分枝杆菌活性及其对分枝杆菌二氢叶酸还原酶的影响。
Antimicrob Agents Chemother. 2000 Oct;44(10):2784-93. doi: 10.1128/AAC.44.10.2784-2793.2000.
3
Knowledge-based scoring function to predict protein-ligand interactions.
通过脒基苯并噻吩衍生物的三维定量构效关系设计和预测新型抗凝剂作为选择性凝血因子IXa抑制剂。
Drug Des Devel Ther. 2015 Mar 23;9:1743-59. doi: 10.2147/DDDT.S75282. eCollection 2015.
4
Identification of new novel scaffold for Aurora A inhibition by pharmacophore modeling and virtual screening.通过药效团建模和虚拟筛选鉴定用于抑制极光激酶A的新型骨架。
Mol Divers. 2014 Nov;18(4):853-63. doi: 10.1007/s11030-014-9535-5. Epub 2014 Aug 12.
用于预测蛋白质-配体相互作用的基于知识的评分函数。
J Mol Biol. 2000 Jan 14;295(2):337-56. doi: 10.1006/jmbi.1999.3371.
4
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.亲脂性抗叶酸剂作为抗机会性感染的药物。1. 在体外评估中对弓形虫和卡氏肺孢子虫优于三甲曲沙和吡利曲辛的药物。
J Med Chem. 1996 Mar 15;39(6):1271-80. doi: 10.1021/jm950760y.
5
Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA.样本距离偏最小二乘法:针对多个变量进行优化的偏最小二乘法及其在比较分子场分析中的应用
J Comput Aided Mol Des. 1993 Oct;7(5):587-619. doi: 10.1007/BF00124364.
6
In vitro and in vivo results of brodimoprim and analogues alone and in combination against E. coli and mycobacteria.溴莫普明及其类似物单独及联合使用对大肠杆菌和分枝杆菌的体外和体内实验结果。
J Chemother. 1993 Dec;5(6):422-9.
7
Basis of selectivity of antibacterial diaminopyrimidines.抗菌二氨基嘧啶的选择性基础。
J Chemother. 1993 Dec;5(6):393-9.
8
Structure-activity relationships of dihydrofolate reductase inhibitors.二氢叶酸还原酶抑制剂的构效关系
J Chemother. 1993 Dec;5(6):377-88.
9
Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.药物分子比较分析中的分子相似性指数(CoMSIA),用于关联和预测其生物活性。
J Med Chem. 1994 Nov 25;37(24):4130-46. doi: 10.1021/jm00050a010.
10
Cross-validated R2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent results.用于比较分子场分析的交叉验证R2引导区域选择:一种获得一致结果的简单方法。
J Med Chem. 1995 Mar 31;38(7):1060-6. doi: 10.1021/jm00007a003.